Breakout Ventures

About Breakout Ventures

Breakout Ventures is a venture capital firm focused on investing early in science-driven technology companies. They partner with exceptional founders to scale scientific innovation, aiming to build category-defining companies at the frontier of science and technology. With over a decade of experience, they provide deep technical understanding, market insight, and a catalytic network to help founders succeed.

Products & Services

Cytovale:Diagnosing immune-mediated diseases.

Modern Meadow:Sustainable biofabrication.

STRM.BIO:In vivo gene therapy.

Ecovative Design:Mycelium-grown materials.

Noetik:Training foundation models to develop cancer immunotherapies.

Epana Bio:Advancing autoimmune care with precision therapies.

ZymoChem:Increasing performance chemical yields with biomanufacturing.

Twelve:Transforming carbon dioxide emissions into useful chemicals.

Specialties

Biotech Tech-Bio Deep Tech Hard Tech Chem Tech Science-Driven Technology Early-Stage Investments

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Fund III T: - FT: Fund III	A: 114000000 MR: - FA: $114M FAN: 114000000	D: 2026-03-10 FD: 2026-03-10	7 investors

Fund III Latest

2026-03-10

$114.0M

7 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

L

Lindy Fishburne

Managing Partner

LinkedIn (Pro only)

D

David Younger

CEO & Co-Founder of A-Alpha Bio

P

Peter Thiel

A

Annie Duke

J

Julia Moore

Managing Partner

I

Ivana Muncie-Vasic

CEO and Co-Founder of Vitra Labs

View 18 more team members with Pro

Unlock Full Team Directory

Recent News